4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0000950170-25-005630
Chief Commercial Officer bought 43,750 shares at $7.60 ($332,413)
From the SEC's structured data for this filing
Cogent Biosciences, Inc. Filed Acc 0000950170-25-005630
Chief Commercial Officer bought 43,750 shares at $7.60 ($332,413)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…